2021
DOI: 10.1007/s12640-021-00346-w
|View full text |Cite
|
Sign up to set email alerts
|

Lacidipine Prevents Scopolamine-Induced Memory Impairment by Reducing Brain Oxido-nitrosative Stress in Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
13
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 81 publications
2
13
0
Order By: Relevance
“…However, AChE overexpression is a reliable marker of aging, inflammatory states, and several diseases, such as hypertension, glaucoma, dementia, and anemia [51,53]. Additionally, scopolamine (i.e., a nonselective anticholinergic medication) was found to increase AChE activity in several different experimental models [54,55], though the role of anticholinergic-induced AChE overexpression in the pathophysiology of anemia is still to be elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…However, AChE overexpression is a reliable marker of aging, inflammatory states, and several diseases, such as hypertension, glaucoma, dementia, and anemia [51,53]. Additionally, scopolamine (i.e., a nonselective anticholinergic medication) was found to increase AChE activity in several different experimental models [54,55], though the role of anticholinergic-induced AChE overexpression in the pathophysiology of anemia is still to be elucidated.…”
Section: Discussionmentioning
confidence: 99%
“…routes. This drug disrupts the cholinergic tracts in areas responsible for cognition and memory [16] , [17] , [18] .…”
Section: Methods Detailsmentioning
confidence: 99%
“… 0.3-0.5mg/kg (i.p.) 72µg/0.5µl (i.c.v) [16] , [17] , [18] 4. AF64A induced memory deficits Male Wistar-Imamichi rats, aged 7-8weeks.…”
Section: Introductionmentioning
confidence: 99%
“…By contrast to neuroprotective effects of P/Q-type and N-type calcium channel blockers, there is a gap for L-type calcium channels blockers in relation to glutamate excitotoxicity (Vallazza-Deschamps et al, 2005;Wheeler et al, 1996). Although there are studies demonstrating the neuroprotective effects of lacidipine and amlodipine which are dihydropyridine calcium channel blockers, evidence supporting their roles as a neuroprotectant factor in glutamate excitotoxicity is almost not available (Choi et al, 2014;Khurana et al, 2021). Both lacidipine and amlodipine block L-channels, but their selectivity is different.…”
Section: Introductionmentioning
confidence: 99%